Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: A randomized double-blind placebo-controlled trial

Journal of Functional Foods

Volumn 6, Issue 1, 2014, Pages 615-622

  Panahi, Yunes ^a   Saadat, Alireza ^a   Beiraghdar, Fatemeh ^a   Hosseini Nouzari, Seyyedeh Mehrabeh ^a   Jalalian, Hamid R ^a   Sahebkar, Amirhossein ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; Carcinogenesis; Catalase; Curcumin; Glutathione; Superoxide dismutase

Indexed keywords

EID: 84895071276     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.12.008     Document Type: Article

References (67)

1. Ak T., Gulcin I. Antioxidant and radical scavenging properties of curcumin. Chemico-Biological Interactions 2008, 174:27-37.
2. Akerboom T.P., Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods in Enzymology 1981, 77:373-382.
3. Alberts D.S., Noel J.K. Cisplatin-associated neurotoxicity: Can it be prevented?. Anti-Cancer Drugs 1995, 6:369-383.
4. Allegri, P., Mastromarino, A., & Neri, P. (2010). Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. 4, 1201-1206.
5. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: Problems and promises. Molecular Pharmaceutics 2007, 4:807-818.
6. Basnet P., Skalko-Basnet N. Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011, 16:4567-4598.
7. Bayet-Robert M., Kwiatkowski F., Leheurteur M., Gachon F., Planchat E., Abrial C., Mouret-Reynier M.A., Durando X., Barthomeuf C., Chollet P. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biology & Therapy 2010, 9:8-14.
8. Belcaro G., Cesarone M.R., Dugall M., Pellegrini L., Ledda A., Grossi M.G., Togni S., Appendino G. Efficacy and safety of Meriva(R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Alternative Medicine Reviews 2010, 15:337-344.
9. Belcaro G., Hosoi M., Pellegrini L., Appendino G., Ippolito E., Ricci A., Ledda A., Dugall M., Cesarone M.R., Maione C., Ciammaichella G., Genovesi D., Togni S. A Controlled study of a lecithinized delivery system of curcumin (Meriva(R)) to alleviate the adverse effects of cancer treatment. Phytotherapy Research 2013.
10. Block K.I., Koch A.C., Mead M.N., Tothy P.K., Newman R.A., Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controlled trials. Cancer Treatment Reviews 2007, 33:407-418.
11. Brouet I., Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochemical and Biophysical Research Communications 1995, 206:533-540.
12. Carroll R.E., Benya R.V., Turgeon D.K., Vareed S., Neuman M., Rodriguez L., Kakarala M., Carpenter P.M., McLaren C., Meyskens F.L., Brenner D.E. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prevention Research (Phila) 2011, 4:354-364.
13. Chan M.M., Huang H.I., Fenton M.R., Fong D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochemical Pharmacology 1998, 55:1955-1962.
14. Chance B., Maehly A.C. Assay of catalase and peroxidase. Methods in enzymology 1995, 2:764-791. New York, Academic Press.
15. Chearwae W., Anuchapreeda S., Nandigama K., Ambudkar S.V., Limtrakul P. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from turmeric powder. Biochemical Pharmacology 2004, 68:2043-2052.
16. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., Hsieh C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research 2001, 21:2895-2900.
17. Cruz-Correa M., Shoskes D.A., Sanchez P., Zhao R., Hylind L.M., Wexner S.D., Giardiello F.M. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clinical Gastroenterology and Hepatology 2006, 4:1035-1038.
18. Cuomo J., Appendino G., Dern A.S., Schneider E., McKinnon T.P., Brown M.J., Togni S., Dixon B.M. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. Journal of Natural Products 2011, 74:664-669.
19. Darvesha A.S., Aggarwal B.B., Bishayee A. Curcumin and liver cancer: A review. Current Pharmaceutical Biotechnology 2012, 13:218-228.
20. Durgaprasad S., Pai C.G., Vasanthkumar Alvres J.F., Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian Journal of Medical Research 2005, 122:315-318.
21. Epelbaum R., Schaffer M., Vizel B., Badmaev V., Bar-Sela G. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutrition and Cancer 2010, 62:1137-1141.
22. Fuchs-Tarlovsky V. Role of antioxidants in cancer therapy. Nutrition 2013, 29:15-21.
23. Garcea G., Berry D.P., Jones D.J., Singh R., Dennison A.R., Farmer P.B., Sharma R.A., Steward W.P., Gescher A.J. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiology, Biomarkers and Prevention 2005, 14:120-125.
24. Gupta S.C., Kismali G., Aggarwal B.B. Curcumin, a component of turmeric: From farm to pharmacy. BioFactors 2013, 39:2-13.
25. Gupta S.C., Patchva S., Aggarwal B.B. Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS Journal 2013, 15:195-218.
26. Gupta S.C., Prasad S., Kim J.H., Patchva S., Webb L.J., Priyadarsini I.K., Aggarwal B.B. Multitargeting by curcumin as revealed by molecular interaction studies. Natural Product Reports 2011, 28:1937-1955.
27. Hasima N., Aggarwal B.B. Cancer-linked targets modulated by curcumin. International Journal of Biochemistry and Molecular Biology 2012, 3:328-351.
28. Hu T.Y., Liu C.L., Chen J.Y., Hu M.L. Curcumin ameliorates methylglyoxal-induced alterations of cellular morphology and hyperpermeability in human umbilical vein endothelial cells. Journal of Functional Foods 2013, 5:745-754.
29. Joe B., Lokesh B.R. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochimica et Biophysica Acta 1994, 1224:255-263.
30. Joe B., Vijaykumar M., Lokesh B.R. Biological properties of curcumin-cellular and molecular mechanisms of action. Critical Reviews in Food Science and Nutrition 2004, 44:97-111.
31. Kanai M., Yoshimura K., Asada M., Imaizumi A., Suzuki C., Matsumoto S., Nishimura T., Mori Y., Masui T., Kawaguchi Y., Yanagihara K., Yazumi S., Chiba T., Guha S., Aggarwal B.B. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemotherapy and Pharmacology 2011, 68:157-164.
32. Kaposztas Z., Kahan B.D., Katz S.M., Van Buren C.T., Cherem L. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: A case report. Transplantation Proceedings 2009, 41:4407-4410.
33. Krishnakumar I.M., Ravi A., Kumar D., Kuttan R., Maliakel B. An enhanced bioavailable formulation of curcumin using fenugreek-derived soluble dietary fibre. Journal of Functional Foods 2012, 4:348-357.
34. KunnumakkarA A.B., Guha S., Aggarwal B.B. Curcumin and colorectal cancer: Add spice to your life. Current Colorectal Cancer Reports 2009, 5:5-14.
35. Ledda A., Belcaro G., Dugall M., Luzzi R., Scoccianti M., Togni S., Appendino G., Ciammaichella G. Meriva(R), a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: A pilot, product evaluation registry study. Panminerva Medica 2012, 54:17-22.
36. Limtrakul P., Anuchapreeda S., Buddhasukh D. Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 2004, 4:13.
37. Marczylo T.H., Verschoyle R.D., Cooke D.N., Morazzoni P., Steward W.P., Gescher A.J. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemotherapy and Pharmacology 2007, 60:171-177.
38. Masuda T., Maekawa T., Hidaka K., Bando H., Takeda Y., Yamaguchi H. Chemical studies on antioxidant mechanism of curcumin: Analysis of oxidative coupling products from curcumin and linoleate. Journal of Agricultural and Food Chemistry 2001, 49:2539-2547.
39. Mazzolani F. Pilot study of oral administration of a curcuminphospholipid formulation for treatment of central serous chorioretinopathy. Clinical Ophthalmology 2012, 6:801-806.
40. Mazzolani F., Togni S. Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: A 12-month follow-up study. Clinical Ophthalmology 2013, 7:939-945.
41. Millsopp L., Frackleton S., Lowe D., Rogers S.N. A feasibility study of computer-assisted health-related quality of life data collection in patients with oral and oropharyngeal cancer. International Journal of Oral and Maxillofacial Surgery 2006, 35:761-764.
42. Mohammadi A., Sahebkar A., Iranshahi M., Amini M., Khojasteh R., Ghayour-Mobarhan M., Ferns G.A. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial. Phytotherapy Research 2013, 27:374-379.
43. Nishikawa H., Tsutsumi J., Kitani S. Anti-inflammatory and anti-oxidative effect of curcumin in connective tissue type mast cell. Journal of Functional Foods 2013, 5:763-772.
44. Panahi Y., Sahebkar A., Amiri M., Davoudi S.M., Beiraghdar F., Hoseininejad S.L., Kolivand M. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: Results of a randomised, double-blind, placebo-controlled trial. British Journal of Nutrition 2012, 108:1272-1279.
45. Panahi Y., Sahebkar A., Parvin S., Saadat A. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Annals of Clinical Biochemistry 2012, 49:580-588.
46. Rai B., Kaur J., Jacobs R., Singh J. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. Journal of Oral Science 2010, 52:251-256.
47. Ravindran J., Prasad S., Aggarwal B.B. Curcumin and cancer cells: How many ways can curry kill tumor cells selectively?. AAPS Journal 2009, 11:495-510.
48. Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: How are they linked?. Free Radical Biology & Medicine 2010, 49:1603-1616.
49. Sahebkar A. Molecular mechanisms for curcumin benefits against ischemic injury. Fertility and Sterility 2010, 94:e75-76. [author reply e77].
50. Sahebkar A. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?. BioFactors 2013, 39:197-208.
51. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytotherapy Research 2013.
52. Sahebkar A. Curcuminoids for the management of hypertriglyceridaemia. Nature Reviews Cardiology 2013, 10.1038/nrcardio.2013.140-c1.
53. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., Marczylo T.H., Morgan B., Hemingway D., Plummer S.M., Pirmohamed M., Gescher A.J., Steward W.P. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clinical Cancer Research 2004, 10:6847-6854.
54. Sharma R.A., McLelland H.R., Hill K.A., Ireson C.R., Euden S.A., Manson M.M., Pirmohamed M., Marnett L.J., Gescher A.J., Steward W.P. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clinical Cancer Research 2001, 7:1894-1900.
55. Shehzad A., Lee J., Lee Y.S. Curcumin in various cancers. BioFactors 2013, 39:56-68.
56. Shehzad A., Rehman G., Lee Y.S. Curcumin in inflammatory diseases. BioFactors 2013, 39:69-77.
57. Shehzad A., Wahid F., Lee Y.S. Curcumin in cancer chemoprevention: Molecular targets, pharmacokinetics, bioavailability, and clinical trials. Archiv der Pharmazie (Weinheim) 2010, 343:489-499.
58. Shigeshiro M., Tanabe S., Suzuki T. Dietary polyphenols modulate intestinal barrier defects and inflammation in a murine model of colitis. Journal of Functional Foods 2013, 5:949-955.
59. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2012, 62:10-29.
60. Sies H. Biochemistry of oxidative stress. Angewandte Chemie International Edition in English 1986, 25:1058.
61. Sosa V., Moline T., Somoza R., Paciucci R., Kondoh H., ME L.L. Oxidative stress and cancer: An overview. Ageing Research Reviews 2013, 12:376-390.
62. Steigerwalt R., Nebbioso M., Appendino G., Belcaro G., Ciammaichella G., Cornelli U., Luzzi R., Togni S., Dugall M., Cesarone M.R., Ippolito E., Errichi B.M., Ledda A., Hosoi M., Corsi M. Meriva(R), a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Medica 2012, 54:11-16.
63. Steward W.P., Gescher A.J. Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future research. Molecular Nutrition & Food Research 2008, 52:1005-1009.
64. Taguchi T., Nazneen A., Abid M.R., Razzaque M.S. Cisplatin-associated nephrotoxicity and pathological events. Contributions to Nephrology 2005, 148:107-121.
65. Temel J.S., Greer J.A., Muzikansky A., Gallagher E.R., Admane S., Jackson V.A., Dahlin C.M., Blinderman C.D., Jacobsen J., Pirl W.F., Billings J.A., Lynch T.J. Early palliative care for patients with metastatic non-small-cell lung cancer. New England Journal of Medicine 2010, 363:733-742.
66. Uchiyama M., Mihara M. Determination of malonaldehyde precursor in tissue by thiobarbituric acid test. Analytical Biochemistry 1978, 34:271-278.
67. Yin W., Zhang X., Shi X., Li Y. Curcumin protects SH-SY5Y cells from oxidative stress by up-regulating HO-1 via Phosphatidylinositol 3 Kinase/Akt/Nrf-2 and down-regulating HO-2. Molecular Neurodegeneration 2012, 7:S14.